Copyright Reports & Markets. All rights reserved.

Global Dermatology OTC Medications Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Dermatology OTC Medications Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 External Use
    • 1.3.3 Oral
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Dermatology OTC Medications Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Drug Store
    • 1.4.4 Other
  • 1.5 Global Dermatology OTC Medications Market Size & Forecast
    • 1.5.1 Global Dermatology OTC Medications Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Dermatology OTC Medications Sales Quantity (2021-2032)
    • 1.5.3 Global Dermatology OTC Medications Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Dermatology OTC Medications Product and Services
    • 2.1.4 Bayer Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK Dermatology OTC Medications Product and Services
    • 2.2.4 GSK Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 Teva
    • 2.3.1 Teva Details
    • 2.3.2 Teva Major Business
    • 2.3.3 Teva Dermatology OTC Medications Product and Services
    • 2.3.4 Teva Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Teva Recent Developments/Updates
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson Dermatology OTC Medications Product and Services
    • 2.4.4 Johnson & Johnson Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Johnson & Johnson Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Dermatology OTC Medications Product and Services
    • 2.5.4 Novartis Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Viatris
    • 2.6.1 Viatris Details
    • 2.6.2 Viatris Major Business
    • 2.6.3 Viatris Dermatology OTC Medications Product and Services
    • 2.6.4 Viatris Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Viatris Recent Developments/Updates
  • 2.7 Sun Pharmaceutical
    • 2.7.1 Sun Pharmaceutical Details
    • 2.7.2 Sun Pharmaceutical Major Business
    • 2.7.3 Sun Pharmaceutical Dermatology OTC Medications Product and Services
    • 2.7.4 Sun Pharmaceutical Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sun Pharmaceutical Recent Developments/Updates
  • 2.8 Aurobindo
    • 2.8.1 Aurobindo Details
    • 2.8.2 Aurobindo Major Business
    • 2.8.3 Aurobindo Dermatology OTC Medications Product and Services
    • 2.8.4 Aurobindo Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Aurobindo Recent Developments/Updates
  • 2.9 Galderma
    • 2.9.1 Galderma Details
    • 2.9.2 Galderma Major Business
    • 2.9.3 Galderma Dermatology OTC Medications Product and Services
    • 2.9.4 Galderma Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Galderma Recent Developments/Updates
  • 2.10 CR SANJIU
    • 2.10.1 CR SANJIU Details
    • 2.10.2 CR SANJIU Major Business
    • 2.10.3 CR SANJIU Dermatology OTC Medications Product and Services
    • 2.10.4 CR SANJIU Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 CR SANJIU Recent Developments/Updates
  • 2.11 Dr. Reddy's
    • 2.11.1 Dr. Reddy's Details
    • 2.11.2 Dr. Reddy's Major Business
    • 2.11.3 Dr. Reddy's Dermatology OTC Medications Product and Services
    • 2.11.4 Dr. Reddy's Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Dr. Reddy's Recent Developments/Updates
  • 2.12 Lupin
    • 2.12.1 Lupin Details
    • 2.12.2 Lupin Major Business
    • 2.12.3 Lupin Dermatology OTC Medications Product and Services
    • 2.12.4 Lupin Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Lupin Recent Developments/Updates
  • 2.13 Bausch Health
    • 2.13.1 Bausch Health Details
    • 2.13.2 Bausch Health Major Business
    • 2.13.3 Bausch Health Dermatology OTC Medications Product and Services
    • 2.13.4 Bausch Health Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Bausch Health Recent Developments/Updates
  • 2.14 Cipla
    • 2.14.1 Cipla Details
    • 2.14.2 Cipla Major Business
    • 2.14.3 Cipla Dermatology OTC Medications Product and Services
    • 2.14.4 Cipla Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Cipla Recent Developments/Updates
  • 2.15 Qilu Pharmaceutical
    • 2.15.1 Qilu Pharmaceutical Details
    • 2.15.2 Qilu Pharmaceutical Major Business
    • 2.15.3 Qilu Pharmaceutical Dermatology OTC Medications Product and Services
    • 2.15.4 Qilu Pharmaceutical Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.16 Almirall
    • 2.16.1 Almirall Details
    • 2.16.2 Almirall Major Business
    • 2.16.3 Almirall Dermatology OTC Medications Product and Services
    • 2.16.4 Almirall Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Almirall Recent Developments/Updates
  • 2.17 Lingrui
    • 2.17.1 Lingrui Details
    • 2.17.2 Lingrui Major Business
    • 2.17.3 Lingrui Dermatology OTC Medications Product and Services
    • 2.17.4 Lingrui Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Lingrui Recent Developments/Updates
  • 2.18 Kaken Pharmaceutical
    • 2.18.1 Kaken Pharmaceutical Details
    • 2.18.2 Kaken Pharmaceutical Major Business
    • 2.18.3 Kaken Pharmaceutical Dermatology OTC Medications Product and Services
    • 2.18.4 Kaken Pharmaceutical Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Kaken Pharmaceutical Recent Developments/Updates
  • 2.19 Jingwei Pharma
    • 2.19.1 Jingwei Pharma Details
    • 2.19.2 Jingwei Pharma Major Business
    • 2.19.3 Jingwei Pharma Dermatology OTC Medications Product and Services
    • 2.19.4 Jingwei Pharma Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Jingwei Pharma Recent Developments/Updates
  • 2.20 Zhiyuan Phamra
    • 2.20.1 Zhiyuan Phamra Details
    • 2.20.2 Zhiyuan Phamra Major Business
    • 2.20.3 Zhiyuan Phamra Dermatology OTC Medications Product and Services
    • 2.20.4 Zhiyuan Phamra Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Zhiyuan Phamra Recent Developments/Updates

3 Competitive Environment: Dermatology OTC Medications by Manufacturer

  • 3.1 Global Dermatology OTC Medications Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Dermatology OTC Medications Revenue by Manufacturer (2021-2026)
  • 3.3 Global Dermatology OTC Medications Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Dermatology OTC Medications by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Dermatology OTC Medications Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Dermatology OTC Medications Manufacturer Market Share in 2025
  • 3.5 Dermatology OTC Medications Market: Overall Company Footprint Analysis
    • 3.5.1 Dermatology OTC Medications Market: Region Footprint
    • 3.5.2 Dermatology OTC Medications Market: Company Product Type Footprint
    • 3.5.3 Dermatology OTC Medications Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Dermatology OTC Medications Market Size by Region
    • 4.1.1 Global Dermatology OTC Medications Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Dermatology OTC Medications Consumption Value by Region (2021-2032)
    • 4.1.3 Global Dermatology OTC Medications Average Price by Region (2021-2032)
  • 4.2 North America Dermatology OTC Medications Consumption Value (2021-2032)
  • 4.3 Europe Dermatology OTC Medications Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Dermatology OTC Medications Consumption Value (2021-2032)
  • 4.5 South America Dermatology OTC Medications Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Dermatology OTC Medications Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Dermatology OTC Medications Sales Quantity by Type (2021-2032)
  • 5.2 Global Dermatology OTC Medications Consumption Value by Type (2021-2032)
  • 5.3 Global Dermatology OTC Medications Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Dermatology OTC Medications Sales Quantity by Application (2021-2032)
  • 6.2 Global Dermatology OTC Medications Consumption Value by Application (2021-2032)
  • 6.3 Global Dermatology OTC Medications Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Dermatology OTC Medications Sales Quantity by Type (2021-2032)
  • 7.2 North America Dermatology OTC Medications Sales Quantity by Application (2021-2032)
  • 7.3 North America Dermatology OTC Medications Market Size by Country
    • 7.3.1 North America Dermatology OTC Medications Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Dermatology OTC Medications Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Dermatology OTC Medications Sales Quantity by Type (2021-2032)
  • 8.2 Europe Dermatology OTC Medications Sales Quantity by Application (2021-2032)
  • 8.3 Europe Dermatology OTC Medications Market Size by Country
    • 8.3.1 Europe Dermatology OTC Medications Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Dermatology OTC Medications Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Dermatology OTC Medications Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Dermatology OTC Medications Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Dermatology OTC Medications Market Size by Region
    • 9.3.1 Asia-Pacific Dermatology OTC Medications Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Dermatology OTC Medications Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Dermatology OTC Medications Sales Quantity by Type (2021-2032)
  • 10.2 South America Dermatology OTC Medications Sales Quantity by Application (2021-2032)
  • 10.3 South America Dermatology OTC Medications Market Size by Country
    • 10.3.1 South America Dermatology OTC Medications Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Dermatology OTC Medications Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Dermatology OTC Medications Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Dermatology OTC Medications Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Dermatology OTC Medications Market Size by Country
    • 11.3.1 Middle East & Africa Dermatology OTC Medications Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Dermatology OTC Medications Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Dermatology OTC Medications Market Drivers
  • 12.2 Dermatology OTC Medications Market Restraints
  • 12.3 Dermatology OTC Medications Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Dermatology OTC Medications and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Dermatology OTC Medications
  • 13.3 Dermatology OTC Medications Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Dermatology OTC Medications Typical Distributors
  • 14.3 Dermatology OTC Medications Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Dermatology OTC Medications market size was valued at US$ 14440 million in 2025 and is forecast to a readjusted size of US$ 17990 million by 2032 with a CAGR of 3.2% during review period.
    Dermatology OTC (Over-the-Counter) medications refer to non-prescription drugs used to prevent, manage, or treat common skin conditions such as acne, eczema, dermatitis, fungal infections, dry skin, sunburn, and minor wounds. These products are widely available in pharmacies, supermarkets, and online, and include creams, ointments, gels, lotions, and medicated cleansers. They typically contain active ingredients like salicylic acid, benzoyl peroxide, hydrocortisone, antifungals, or antihistamines, and are designed for safe use without a doctor’s prescription, offering convenient and cost-effective solutions for everyday dermatologic care.
    Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.
    This report is a detailed and comprehensive analysis for global Dermatology OTC Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Dermatology OTC Medications market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Dermatology OTC Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Dermatology OTC Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Dermatology OTC Medications market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Dermatology OTC Medications
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Dermatology OTC Medications market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, GSK, Teva, Johnson & Johnson, Novartis, Viatris, Sun Pharmaceutical, Aurobindo, Galderma, CR SANJIU, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Dermatology OTC Medications market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    External Use
    Oral
    Market segment by Application
    Hospital
    Drug Store
    Other
    Major players covered
    Bayer
    GSK
    Teva
    Johnson & Johnson
    Novartis
    Viatris
    Sun Pharmaceutical
    Aurobindo
    Galderma
    CR SANJIU
    Dr. Reddy's
    Lupin
    Bausch Health
    Cipla
    Qilu Pharmaceutical
    Almirall
    Lingrui
    Kaken Pharmaceutical
    Jingwei Pharma
    Zhiyuan Phamra
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Dermatology OTC Medications product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Dermatology OTC Medications, with price, sales quantity, revenue, and global market share of Dermatology OTC Medications from 2021 to 2026.
    Chapter 3, the Dermatology OTC Medications competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Dermatology OTC Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Dermatology OTC Medications market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Dermatology OTC Medications.
    Chapter 14 and 15, to describe Dermatology OTC Medications sales channel, distributors, customers, research findings and conclusion.

    Buy now